APA (7th ed.) Citation

JC, L., TS, H., YB, C., TY, C., PS, W., TP, L., & PM, Y. (2026). LDN-57444 sensitizes hepatocellular carcinoma cells to sorafenib by promoting ferroptosis through histone deacetylase 2 (HDAC2) inhibition. Biology direct, 21(1), . https://doi.org/10.1186/s13062-026-00735-1

Chicago Style (17th ed.) Citation

JC, Lin, Huang TS, Chen YB, Chen TY, Wu PS, Liu TP, and Yang PM. "LDN-57444 Sensitizes Hepatocellular Carcinoma Cells to Sorafenib by Promoting Ferroptosis Through Histone Deacetylase 2 (HDAC2) Inhibition." Biology Direct 21, no. 1 (2026). https://doi.org/10.1186/s13062-026-00735-1.

MLA (9th ed.) Citation

JC, Lin, et al. "LDN-57444 Sensitizes Hepatocellular Carcinoma Cells to Sorafenib by Promoting Ferroptosis Through Histone Deacetylase 2 (HDAC2) Inhibition." Biology Direct, vol. 21, no. 1, 2026, https://doi.org/10.1186/s13062-026-00735-1.